Chemoreduction for Group E Retinoblastoma: Comparison of Chemoreduction Alone Versus Chemoreduction Plus Low-Dose External Radiotherapy in 76 Eyes
- 31 March 2009
- journal article
- research article
- Published by Elsevier BV in Ophthalmology
- Vol. 116 (3), 544-551.e1
- https://doi.org/10.1016/j.ophtha.2008.10.014
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Treatment of Pediatric Hodgkin LymphomaCurrent Treatment Options in Oncology, 2008
- The International Classification of Retinoblastoma Predicts Chemoreduction SuccessOphthalmology, 2006
- Survival and Late Effects in Children With Hodgkin's Lymphoma Treated With MOPP/ABV and Low-Dose, Extended-Field IrradiationJournal of Clinical Oncology, 2006
- Basic understanding of current classification and management of retinoblastomaCurrent Opinion in Opthalmology, 2006
- Intraocular Retinoblastoma: the Case for a New Group ClassificationOphthalmology Clinics of North America, 2005
- CONTINUING CHALLENGES IN THE MANAGEMENT OF RETINOBLASTOMA WITH CHEMOTHERAPYRetina, 2004
- Causes of chemoreduction failure in retinoblastoma and analysis of associated factors leading to eventual treatment with external beam radiotherapy and enucleationOphthalmology, 2004
- Outcome Following Initial External Beam Radiotherapy in Patients WithReese-Ellsworth Group Vb RetinoblastomaAmerican Journal of Ophthalmology, 2004
- Chemoreduction plus focal therapy for retinoblastoma: factors predictive of need for treatment with external beam radiotherapy or enucleationAmerican Journal of Ophthalmology, 2002
- The Outcome of Chemoreduction Treatment in Patients With Reese-Ellsworth Group V RetinoblastomaAmerican Journal of Ophthalmology, 1998